DDS vs. NVO
Compare and contrast key facts about Dillard's, Inc. (DDS) and Novo Nordisk A/S (NVO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: DDS or NVO.
Correlation
The correlation between DDS and NVO is 0.13, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
DDS vs. NVO - Performance Comparison
Key characteristics
DDS:
0.49
NVO:
-0.64
DDS:
0.96
NVO:
-0.71
DDS:
1.12
NVO:
0.90
DDS:
0.65
NVO:
-0.52
DDS:
1.40
NVO:
-1.40
DDS:
13.96%
NVO:
16.43%
DDS:
39.68%
NVO:
35.90%
DDS:
-93.94%
NVO:
-71.30%
DDS:
-4.63%
NVO:
-44.53%
Fundamentals
DDS:
$6.93B
NVO:
$373.83B
DDS:
$38.75
NVO:
$2.91
DDS:
11.25
NVO:
27.90
DDS:
-1.28
NVO:
1.22
DDS:
$6.67B
NVO:
$204.72B
DDS:
$2.58B
NVO:
$173.22B
DDS:
$964.29M
NVO:
$108.42B
Returns By Period
In the year-to-date period, DDS achieves a 0.99% return, which is significantly higher than NVO's -5.63% return. Over the past 10 years, DDS has outperformed NVO with an annualized return of 17.11%, while NVO has yielded a comparatively lower 16.22% annualized return.
DDS
0.99%
2.93%
8.65%
20.01%
51.07%
17.11%
NVO
-5.63%
-24.10%
-42.16%
-23.41%
23.56%
16.22%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
DDS vs. NVO — Risk-Adjusted Performance Rank
DDS
NVO
DDS vs. NVO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Dillard's, Inc. (DDS) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
DDS vs. NVO - Dividend Comparison
DDS's dividend yield for the trailing twelve months is around 5.96%, more than NVO's 1.78% yield.
TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Dillard's, Inc. | 5.96% | 6.02% | 5.18% | 4.89% | 6.41% | 0.95% | 0.68% | 0.66% | 0.57% | 0.45% | 0.40% | 0.19% |
Novo Nordisk A/S | 1.78% | 1.68% | 0.99% | 1.18% | 1.34% | 1.86% | 2.14% | 2.47% | 2.12% | 3.93% | 1.31% | 1.96% |
Drawdowns
DDS vs. NVO - Drawdown Comparison
The maximum DDS drawdown since its inception was -93.94%, which is greater than NVO's maximum drawdown of -71.30%. Use the drawdown chart below to compare losses from any high point for DDS and NVO. For additional features, visit the drawdowns tool.
Volatility
DDS vs. NVO - Volatility Comparison
The current volatility for Dillard's, Inc. (DDS) is 8.42%, while Novo Nordisk A/S (NVO) has a volatility of 21.18%. This indicates that DDS experiences smaller price fluctuations and is considered to be less risky than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
DDS vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between Dillard's, Inc. and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities